Health Canada licensed products
Seegene’s Health Canada licensed “All in One” assays test multiple pathogens at once using a single platform and achieving exceptional performance.
An all-in-one platform
Seegene’s “All in One” assays test multiple targets at once, saving time, increasing capacity, and generating gold standard results.
Health Canada licensed
Seegene Canada’s multiplex real-time PCR assay’s are Health Canada licensed and are playing a crucial role in the country’s efforts to respond to the health needs of Canadians.
The Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay is a multiplex real-time PCR assay designed to detect SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) A/B in a single tube. The assay uses Seegene’s integrated All-in-One automated platform to achieve high-throughput capacity and exceptional results.
Allplex™ 2019-nCoV Assay
The Allplex™ 2019-nCoV Assay simultaneously detects and identifies 3 target genes specific for COVID-19 in a single tube. The Allplex™ 2019-nCoV Assay uses multiplex, real-time PCR testing technology to achieve fast results, efficient workflow, and outstanding sensitivity and precision.
Allplex™ GI-Virus Assay
The Allplex™ GI-Virus Assay detects and identifies 6 viruses causing gastrointestinal tract infections using one-step, “all in one,” real-time PCR technology. Using Seegene’s proprietary MuDT™ technology, this assay reports multiple Ct values of each pathogen in a single channel and is highly effective and efficient.
Allplex™ GI-Parasite Assay
The Allplex™ GI-Parasite Assay detects and identifies 6 parasites causing gastrointestinal diseases using real-time PCR. Powerful performance is achieved using Seegene’s “all in one” PCR technology.